Works matching IS 1007385X AND DT 2021 AND VI 28 AND IP 10

Results: 13

下调miR-183 靶向肿瘤抑制因子CPEB1 增强脑胶质瘤细胞的放射敏感性.

Published in:

Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 10, p. 1015, doi. 10.3872/j.issn.1007-385x.2021.10.009

By:

杨森;
董立新;
张彦秋;
付宝红;
曹丽艳;
毛羽;
张庆怀;
王光霞;
付占昭;
吴磊;
王东

Publication type:

Article

linc00941 通过miR-203/CCL2 轴调控食管鳞状细胞癌细胞增殖、侵袭和糖酵解.

Published in:

Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 10, p. 1005, doi. 10.3872/j.issn.1007-385x.2021.10.008

By:

乔飞;
李柏钧;
李晓明;
黄国胜;
陈鸿运;
张要盛

Publication type:

Article

结直肠癌分子分型的研究进展.

Published in:

Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 10, p. 1037, doi. 10.3872/j.issn.1007-385x.2021.10.012

By:

岳源;
综述;
李西川;
张春泽;
审阅

Publication type:

Article

PD-1/PD-L1 免疫检查点抑制剂治疗肝细胞癌的临床试验研究进展.

Published in:

Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 10, p. 1029, doi. 10.3872/j.issn.1007-385x.2021.10.011

By:

余滢滢;
综述;
孟繁平;
王福生;
施明;
审阅

Publication type:

Article

调节性B细胞在肿瘤中的研究进展.

Published in:

Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 10, p. 1023, doi. 10.3872/j.issn.1007-385x.2021.10.010

By:

陈煜璐;
综述;
钱莉审阅

Publication type:

Article

晚期胃癌及胃食管交界癌的免疫治疗现状及进展.

Published in:

Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 10, p. 1041, doi. 10.3872/j.issn.1007-385x.2021.10.013

By:

周莉综述;
刘亮;
任秀宝审阅

Publication type:

Article

肺腺癌穿膜蛋白125 通过高甲基化介导NF-κB 信号通路的激活降低对地西他滨的敏感性

Published in:

Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 10, p. 998, doi. 10.3872/j.issn.1007-385x.2021.10.007

By:

郑亚妹;
符诒慧;
朱轶轲;
陈永倖

Publication type:

Article

基因DCAF8 在多发性骨髓瘤中的临床意义.

Published in:

Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 10, p. 990, doi. 10.3872/j.issn.1007-385x.2021.10.006

By:

孙浩;
王可飞;
方腾;
郝牧

Publication type:

Article

miR-627-3p 在食管鳞状细胞癌组织中的表达及其对癌细胞恶性生物学行为的影响.

Published in:

Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 10, p. 978, doi. 10.3872/j.issn.1007-385x.2021.10.004

By:

朱永刚;
田子强;
赵振翔;
王明博;
曹峰;
温士旺;
李振华;
单保恩

Publication type:

Article

盐酸石蒜碱通过circASH2L/miR-124-3p 轴调控肝癌HCCLM3 细胞的恶性生物学行为.

Published in:

Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 10, p. 969, doi. 10.3872/j.issn.1007-385x.2021.10.003

By:

苏珊珊;
王怀璋;
唐玉君;
万家鑫

Publication type:

Article

lncRNA HOTTIP通过miR⁃637/KLK4 轴促进肺癌SPC⁃A⁃1 细胞的恶性生物学行为.

Published in:

Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 10, p. 961, doi. 10.3872/j.issn.1007-385x.2021.10.002

By:

张东伟;
蓝冰;
蔡双启;
钟家将;
邹家威;
张真强

Publication type:

Article

曹雪涛院士专访：从基础研究到临床转化, 我们应该做些什么？.

Published in:: Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 10, p. 957, doi. 10.3872/j.issn.1007-385x.2021.10.001
Publication type:: Article

干扰FBXO2 表达对胃癌细胞增殖、侵袭、迁移及EMT的影响.

Published in:

Chinese Journal of Cancer Biotherapy, 2021, v. 28, n. 10, p. 985, doi. 10.3872/j.issn.1007-385x.2021.10.005

By:

孙旭;
朱军;
李鑫;
冯彩云;
徐玲;
赵琛健;
章壮军;
茆玲

Publication type:

Article